Reuters logo
BRIEF-AstraZeneca says internal drug development bigger focus than external deals
February 6, 2014 / 10:31 AM / in 4 years

BRIEF-AstraZeneca says internal drug development bigger focus than external deals

Feb 6 (Reuters) - AstraZeneca PLC CEO Pascal Soriot told reporters: * CEO says internal drug development a bigger focus in 2014 than external

deal-making * CEO says needs large acquisition even less than a year ago *

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below